← Leaderboards
Robert O Morgan
University Of Miami Coral Gables
$2,666,459
Attributed
$2,666,459
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $106.4K · FY2005–06$200K$150K$100K$50K$0
'05
'06
Funding mix
By agency
NIH$2,666,459 · 5
By mechanism
R01$1,403,422 · 1
P01$1,065,146 · 1
M01$197,891 · 3
Top collaborators
No co-investigators on record.
Most similar at University Of Miami Coral Gables
Same institution · by research overlap
- Charles S Carver$1,771,918
- Suzanne C Lechner$3,044,207
- Gail H Ironson$7,400,938
- Gail Shor-Posner$5,811,109
Others in their field
Top investigators on “Data Collection Methodology /Evaluation”
- Andrzej Joachimiak Joachimiak · University Of Chicago$33,231,516
- John J Crowley · Fred Hutchinson Cancer Research Center$31,614,221
- Rohit Varma · University Of Southern California$23,288,561
- Philip J Disaia · University Of California Irvine$21,551,991
- Stephen K Burley · Rockefeller University$20,385,391
- Constantine A. Gatsonis · Miriam Hospital$18,065,686
Research focus
Data Collection Methodology /EvaluationHuman Old Age (65+)Biomedical FacilityPersonal ComputersInformation DisseminationAgingStatistics /BiometryTrainingComputer Human InteractionHuman DataData ManagementHuman SubjectClinical ResearchCaucasian AmericanAfrican AmericanHealth Care Service AvailabilityHispanic AmericansHealth Care PolicyHealth BehaviorBehavioral /Social Science Research TagHealth Care QualityHealth Care ServiceHealth AdministrationHealth Services Research Tag
Grant awards (15)
PHI-39: PHASE I TRIAL OF #7389 (HALICHONDRIN B ANALOG) (NSC #707389)$10,886
M01 · FY2006 · RR · contact PI
PHI-39: PHASE I TRIAL OF #7389 (HALICHONDRIN B ANALOG) (NSC #707389)$104,330
M01 · FY2005 · RR
PHI-33: PHASE I TRIAL OF TANDEM CHEMOTHERAPY CYCLES AS CONSOLIDATION THERAPY$2,067
M01 · FY2005 · RR
Medicare + Choice a nd Minority Elderly$460,834
R01 · FY2004 · AG
PHI-33: Phase I Trial of Tandem Chemotherapy Cycles$80,608
M01 · FY2004 · RR
Medicare + Choice a nd Minority Elderly$491,811
R01 · FY2003 · AG
Medicare + Choice a nd Minority Elderly$48,949
R01 · FY2003 · AG
Medicare + Choice and Minority Elderly$401,828
R01 · FY2002 · AG
CORE--DATA MANAGEMENT /STATISTICAL$242,857
P01 · FY2002 · AG
CORE--DATA MANAGEMENT /STATISTICAL$242,857
P01 · FY2002 · AG
CORE--DATA MANAGEMENT /STATISTICAL$289,716
P01 · FY2001 · AG
CORE--DATA MANAGEMENT /STATISTICAL$0
P01 · FY2001 · AG
CORE--DATA MANAGEMENT /STATISTICAL$289,716
P01 · FY2000 · AG
CORE--DATA MANAGEMENT /STATISTICAL$0
P01 · FY2000 · AG
CORE--DATA MANAGEMENT /STATISTICAL$0
P01 · FY2000 · AG